These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12378966)

  • 21. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of gastroretentive sustained release tablets prepared by combination of melt/sublimation actions of L-menthol and penetration of molten polymers into tablets.
    Fukuda M; Goto A
    Chem Pharm Bull (Tokyo); 2011; 59(10):1221-6. PubMed ID: 21963630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet.
    Alhmoud H; Akkam Y; Omari D; Alghananim A; Melhem MB
    Int J Pharm Compd; 2023; 27(5):431-439. PubMed ID: 37816185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the influencing factors on the drug release from sodium alginate matrices].
    Nie SF; Wu XM; Liu HF; Jiang HW; Pan WS
    Yao Xue Xue Bao; 2004 Jul; 39(7):561-5. PubMed ID: 15493851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of carrageenan in mixture with microcrystalline cellulose and its functionality for making tablets.
    Picker KM
    Eur J Pharm Biopharm; 1999 Jul; 48(1):27-36. PubMed ID: 10477325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zero-order drug release from hydrocolloid matrices.
    Möckel JE; Lippold BC
    Pharm Res; 1993 Jul; 10(7):1066-70. PubMed ID: 8378249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
    Ghaly ES; Malavé MI; Rivera WJ; Martí A
    P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
    Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix tablets of carrageenans. II. Release behavior and effect of added cations.
    Picker KM
    Drug Dev Ind Pharm; 1999 Mar; 25(3):339-46. PubMed ID: 10071827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
    Emeje MO; Kunle OO; Ofoefule SI
    Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer.
    Gonzalez YM; Ghaly ES
    Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug release from MCC- and carrageenan-based pellets: experiment and theory.
    Kranz H; Jürgens K; Pinier M; Siepmann J
    Eur J Pharm Biopharm; 2009 Oct; 73(2):302-9. PubMed ID: 19465119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the Dissolution Profile of Gliclazide Modified-Release Tablets Using Different Apparatuses and Dissolution Conditions.
    Skripnik KKS; Riekes MK; Pezzini BR; Cardoso SG; Stulzer HK
    AAPS PharmSciTech; 2017 Jul; 18(5):1785-1794. PubMed ID: 27800567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.